ArticleBMC public health2025
Documentation of lead exposure-associated comorbidity among 4538 workers in China.
Article in BMC public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSystematic documentation of morbidity with exposure assessment in a large group of lead (Pb)-exposed workers in China.
methodsUsing the cluster sampling method, Pb-exposed workers were recruited from a factory in the Henan Province, China. The morbidity information and blood lead concentration (BLC) from each worker were collected. Relationships between the two sets of data were analyzed using the logistic regression and restricted cubic spline (RCS) models.
resultsAmong the 4538 recruited workers, there were 2780 males and 1758 females, with a median age of 34 years old, and BLC ranging from 7.70 to 722.70 μg/l. Among them, 1247 (27.4%) had multiple morbidities (comorbidity). Those with the highest BLC showed a 1.79-fold (significant) increase in comorbidities compared to those with the lowest BLC (95% confidence interval = 1.43, 2.25; p < 0.001). In addition, the comorbidities exhibited a BLC dose-response relationship (p < 0.001), after adjusting for potential confounding factors. The RCS curve analysis revealed a nonlinear relationship between BLC and risk of comorbidity (p-overall < 0.001, and p-nonlinear < 0.001). Sensitivity analysis further confirmed the dose-response relationship between BLC and the risk of developing comorbidities. Additionally, the data indicate that female workers were more susceptible to comorbidities.
conclusionOur study demonstrates that comorbidity was prevalent and was dose-dependent among lead exposed workers.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.